Ke. Gropp et al., DIFFERENTIAL EXPRESSION OF PHOTORECEPTOR-SPECIFIC PROTEINS DURING DISEASE AND DEGENERATION IN THE PROGRESSIVE ROD-CONE DEGENERATION (PRCD) RETINA, Experimental Eye Research, 64(6), 1997, pp. 875-886
Progressive rod-cone degeneration (prcd) is a late-onset hereditary re
tinal degeneration characterized by normal development of photorecepto
rs prior to degeneration and death of visual cells. We reported previo
usly that expression of opsin mRNA and protein decreases prior to visu
al cell degeneration. To examine the specificity of this reduction, we
have used immunocytochemistry to correlate photoreceptor-specific pro
tein expression with visual cell disease progression, Eyes from light-
adapted age-matched control and prcd-affected dogs were fixed in paraf
ormaldehyde, embedded in diethylene glycol distearate (DGD) wax, and r
eacted with antibodies specific to interphotoreceptor retinoid-binding
protein (IRBP), S-antigen, opsin, phosducin, gamma-phosphodiesterase
(gamma-PDE), and beta(1)-transducin. While IRBP expression did not cha
nge with disease progression, immunoreactivity to other proteins varie
d. For S-antigen and opsin, immunoreactivity decreased dramatically wi
th the transition from photoreceptor disease to degeneration; gamma-PD
E immunolabeling in rods also decreased, but the reduction was less ab
rupt. However, for two other proteins (phosducin and beta(1)-transduci
n), immunoreactivity increased initially and was redistributed (partic
ularly to the rod outer segment) in early disease (stage 1). Our resul
ts show that there is a differential expression of photoreceptor-speci
fic proteins with disease and degeneration that is not uniform for all
the gene products examined; expression can be decreased, altered in d
istribution or remain unchanged, It is clear that the decrease of opsi
n expression described previously is not an isolated phenomenon in the
progression of prcd, but is part of a more generalized degenerative p
rocess which eventually culminates in cell death, (C) 1997 Academic Pr
ess Limited.